IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH

Background Worldwide, gastric cancer is the fourth cancer in incidence and the second most common cause of cancer death. Gastric cancer is asymptomatic in the early stages and very often diagnosed at advanced stages, determining a dismal prognosis. Expression of the HER2 gene has been identified in...

Full description

Bibliographic Details
Main Authors: Diego Michelon DE CARLI, Marta Pires da ROCHA, Luis Carlos Moreira ANTUNES, Renato Borges FAGUNDES
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) 2015-06-01
Series:Arquivos de Gastroenterologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032015000200152&lng=en&tlng=en
id doaj-2848427aa894463a897dbd6b8fad61e5
record_format Article
spelling doaj-2848427aa894463a897dbd6b8fad61e52020-11-25T00:11:06ZengInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)Arquivos de Gastroenterologia1678-42192015-06-0152215215510.1590/S0004-28032015000200015S0004-28032015000200152IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACHDiego Michelon DE CARLIMarta Pires da ROCHALuis Carlos Moreira ANTUNESRenato Borges FAGUNDESBackground Worldwide, gastric cancer is the fourth cancer in incidence and the second most common cause of cancer death. Gastric cancer is asymptomatic in the early stages and very often diagnosed at advanced stages, determining a dismal prognosis. Expression of the HER2 gene has been identified in about 20% of gastric cancer cases, and its hyper-expression is associated with poor prognosis. Objective To investigate HER2 immunohistochemical expression in gastric adenocarcinoma and its relationship to the histological type and anatomic location. Methods A cross-sectional retrospective study analyzed the immunohistochemical expression of HER2 in a sample of 48 specimens of gastric cancer. Immunohistochemical analysis were performed using avidin-biotin-peroxidase method with C-erb B2 (clone EP1045Y), as a primary antibody (Biocare Medical, USA). Standardized gastric adenocarcinoma‘s HER2 expression criteria has been used in the analysis of samples. Results There were seven cases with reactivity for HER2. Five were of intestinal-type while two cases were of mixed-type in which the expression occurred in the intestinal component. It was identified a significant association of HER2 expression in the intestinal subtype of gastric adenocarcinoma (P=0.003). Regarding the anatomical site, HER2 was positive in only one (16.6%) of the six proximal cases and six (14.28%) of the 42 distal cases (P=0.88). Conclusion HER2 immunoexpression was identified in 14.6% of the samples, and the expression was significantly associated to Lauren’s intestinal subtype.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032015000200152&lng=en&tlng=enImuno-histoquímicaNeoplasias gástricasGenes erbB-2
collection DOAJ
language English
format Article
sources DOAJ
author Diego Michelon DE CARLI
Marta Pires da ROCHA
Luis Carlos Moreira ANTUNES
Renato Borges FAGUNDES
spellingShingle Diego Michelon DE CARLI
Marta Pires da ROCHA
Luis Carlos Moreira ANTUNES
Renato Borges FAGUNDES
IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH
Arquivos de Gastroenterologia
Imuno-histoquímica
Neoplasias gástricas
Genes erbB-2
author_facet Diego Michelon DE CARLI
Marta Pires da ROCHA
Luis Carlos Moreira ANTUNES
Renato Borges FAGUNDES
author_sort Diego Michelon DE CARLI
title IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH
title_short IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH
title_full IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH
title_fullStr IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH
title_full_unstemmed IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH
title_sort immunohistochemical expression of her2 in adenocarcinoma of the stomach
publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
series Arquivos de Gastroenterologia
issn 1678-4219
publishDate 2015-06-01
description Background Worldwide, gastric cancer is the fourth cancer in incidence and the second most common cause of cancer death. Gastric cancer is asymptomatic in the early stages and very often diagnosed at advanced stages, determining a dismal prognosis. Expression of the HER2 gene has been identified in about 20% of gastric cancer cases, and its hyper-expression is associated with poor prognosis. Objective To investigate HER2 immunohistochemical expression in gastric adenocarcinoma and its relationship to the histological type and anatomic location. Methods A cross-sectional retrospective study analyzed the immunohistochemical expression of HER2 in a sample of 48 specimens of gastric cancer. Immunohistochemical analysis were performed using avidin-biotin-peroxidase method with C-erb B2 (clone EP1045Y), as a primary antibody (Biocare Medical, USA). Standardized gastric adenocarcinoma‘s HER2 expression criteria has been used in the analysis of samples. Results There were seven cases with reactivity for HER2. Five were of intestinal-type while two cases were of mixed-type in which the expression occurred in the intestinal component. It was identified a significant association of HER2 expression in the intestinal subtype of gastric adenocarcinoma (P=0.003). Regarding the anatomical site, HER2 was positive in only one (16.6%) of the six proximal cases and six (14.28%) of the 42 distal cases (P=0.88). Conclusion HER2 immunoexpression was identified in 14.6% of the samples, and the expression was significantly associated to Lauren’s intestinal subtype.
topic Imuno-histoquímica
Neoplasias gástricas
Genes erbB-2
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032015000200152&lng=en&tlng=en
work_keys_str_mv AT diegomichelondecarli immunohistochemicalexpressionofher2inadenocarcinomaofthestomach
AT martapiresdarocha immunohistochemicalexpressionofher2inadenocarcinomaofthestomach
AT luiscarlosmoreiraantunes immunohistochemicalexpressionofher2inadenocarcinomaofthestomach
AT renatoborgesfagundes immunohistochemicalexpressionofher2inadenocarcinomaofthestomach
_version_ 1725405219900096512